Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Sanofi Pasteur, UC San Diego target acne treatment
November 2011
SHARING OPTIONS:

LYON, France—A new research and development collaboration between Sanofi Pasteur, the vaccines division of Sanofi, and the University of California, San Diego (UC San Diego) will focus on an immunological approach to acne prevention and treatment targeting the specific neutralization of Propionibacterium acnes factors in inflammation. Acne affects more than 50 million people just in the United States, and is associated with the Gram-positive anaerobic bacterium P. acnes. Currently, treatment of mild forms of acne involves killing P. acnes with benzoyl peroxide and oral or topical antibiotics, a method that kills many bacterial species, disrupts the skin's normal balance and can lead to resistant strains of P. acnes. The agreement provides for a two-year research collaboration between Dr. Chun- Ming Huang and his associates at UC San Diego School of Medicine for additional research and development. Financial details were not disclosed.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.